United States· US:85816-1006_44f9f008-2021-a802-e063-6394a90a26f9

BM Kali Phos

A medicinal product containing potassium phosphate, dibasic, registered in United States by BM Private Limited.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBM Kali PhosATC—REGISTER NO.US:85816-1006_44f9f00…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
POTASSIUM PHOSPHATE, DIBASIC
Manufacturer
BM Private Limited
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    8581610061
    30000 mg in 1 BOTTLE, GLASS (85816-1006-1)
  • ndc11
    8581610062
    500000 mg in 1 JAR (85816-1006-2)
  • ndc11
    85816-1006-1
  • ndc11
    85816-1006-2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Potassium phosphate, dibasic in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All potassium phosphate, dibasic products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Spain · Fosfato Dipotasico 1m Fresenius Kabi
  • France · Phosphate Dipotassique Renaudin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8509033-d069-4495-9206-62e84604d931
GET /v1/drugs/d8509033-d069-4495-9206-62e84604d931?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "6",
  "substance": "POTASSIUM PHOSPHATE, DIBASIC",
  "productndc": "85816-1006",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/60mg",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about potassium phosphate, dibasic.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.